BIS is applicable to all cancer/ treatments involving radiation.
Breakeven question, TBA. Recently changed in sales leadership and improved capacity to sales and marketing effort. (IPD expected NCCN inclusion last year so they should be prepared for this eventuality).
Private payer reimbursement 4 point strategies, targeting low hanging fruit. Watch out for next quarter.
Aim leverage NCCN and support from advocacy to get this BIS into standard of care on national level.
NCCN will enable out of cycle negotiation with private payers instead once a year.
Tape vs BIS
- Forums
- ASX - By Stock
- Ann: ImpediMed NCCN Investor Update Conference Call Notification
BIS is applicable to all cancer/ treatments involving...
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
-0.001(0.89%) |
Mkt cap ! $117.3M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.6¢ | $21.68K | 387.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 424164 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 91206 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 424164 | 0.055 |
3 | 255555 | 0.054 |
4 | 330710 | 0.053 |
1 | 130000 | 0.052 |
3 | 42222 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 91206 | 2 |
0.058 | 125188 | 2 |
0.059 | 110002 | 1 |
0.060 | 41689 | 2 |
0.063 | 60166 | 1 |
Last trade - 11.41am 16/08/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online